161 related articles for article (PubMed ID: 31739939)
1. Hematologic Malignancies.
Tseng YD; Ng AK
Hematol Oncol Clin North Am; 2020 Feb; 34(1):127-142. PubMed ID: 31739939
[TBL] [Abstract][Full Text] [Related]
2. Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations.
Ollivier L; Debbi K; To NH; Cailleteau A; Supiot S; Mervoyer A; Guimas V; Belkacémi Y
Cancer Radiother; 2024 Feb; 28(1):119-130. PubMed ID: 38143233
[TBL] [Abstract][Full Text] [Related]
3. Evolving role of radiation therapy for hematologic malignancies.
Lee CK
Hematol Oncol Clin North Am; 2006 Apr; 20(2):471-503. PubMed ID: 16730303
[TBL] [Abstract][Full Text] [Related]
4. Malignant (Diffuse) Mesothelioma in Patients With Hematologic Malignancies: A Clinicopathologic Study of 45 Cases.
Li X; Brownlee NA; Sporn TA; Mahar A; Roggli VL
Arch Pathol Lab Med; 2015 Sep; 139(9):1129-36. PubMed ID: 25844559
[TBL] [Abstract][Full Text] [Related]
5. Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies.
Dabaja BS; Ng AK; Terezakis SA; Plastaras JP; Yunes M; Wilson LD; Specht L; Yahalom J
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):279-281. PubMed ID: 31928641
[No Abstract] [Full Text] [Related]
6. Monoclonal antibodies in the treatment of hematologic malignancies: radiation dosimetry aspects.
Stabin MG; Brill AB
Curr Pharm Biotechnol; 2001 Dec; 2(4):351-6. PubMed ID: 11762416
[TBL] [Abstract][Full Text] [Related]
7. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
8. Targeted Alpha-Particle Therapy for Hematologic Malignancies.
Jurcic JG
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S53-S57. PubMed ID: 31253514
[TBL] [Abstract][Full Text] [Related]
9. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
Specht L; Yahalom J; Illidge T; Berthelsen AK; Constine LS; Eich HT; Girinsky T; Hoppe RT; Mauch P; Mikhaeel NG; Ng A;
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):854-62. PubMed ID: 23790512
[TBL] [Abstract][Full Text] [Related]
10. Linear accelerator-based intensity-modulated total marrow irradiation technique for treatment of hematologic malignancies: a dosimetric feasibility study.
Yeginer M; Roeske JC; Radosevich JA; Aydogan B
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1256-65. PubMed ID: 21035960
[TBL] [Abstract][Full Text] [Related]
11. Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part II-leukemia and myeloma.
Featherstone C; Delaney G; Jacob S; Barton M
Cancer; 2005 Jan; 103(2):393-401. PubMed ID: 15593373
[TBL] [Abstract][Full Text] [Related]
12. Splenic irradiation in hematologic malignancies and other hematologic disorders--single institution experience.
Soldić Z; Murgić J; Jazvić M; Radić J; Bolanca A; Stancić V; Kusić Z
Acta Clin Croat; 2011 Mar; 50(1):29-35. PubMed ID: 22034781
[TBL] [Abstract][Full Text] [Related]
13. In the Battle Between Protons and Photons for Hematologic Malignancies, the Patient Must Win.
Dabaja BS; Mikhaeel NG
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):43-45. PubMed ID: 27084623
[No Abstract] [Full Text] [Related]
14. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Specht L
Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
[TBL] [Abstract][Full Text] [Related]
15. Quality Assurance Peer Review for Radiotherapy for Haematological Malignancies.
Samuel R; Thomas E; Gilson D; Prestwich RJD
Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):e1-e8. PubMed ID: 31296456
[TBL] [Abstract][Full Text] [Related]
16. An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies.
Shea TC; Bruner R; Wiley JM; Serody JS; Sailer S; Gabriel DA; Capel E; Moore DT; Dent G; Bentley S; Brecher ME
Biol Blood Marrow Transplant; 2003 Jul; 9(7):443-52. PubMed ID: 12869958
[TBL] [Abstract][Full Text] [Related]
17. Pemphigus and hematologic malignancies: A population-based study of 11,859 patients.
Kridin K; Zelber-Sagi S; Comaneshter D; Batat E; Cohen AD
J Am Acad Dermatol; 2018 Jun; 78(6):1084-1089.e1. PubMed ID: 29198780
[TBL] [Abstract][Full Text] [Related]
18. Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part I-lymphoma.
Featherstone C; Delaney G; Jacob S; Barton M
Cancer; 2005 Jan; 103(2):383-92. PubMed ID: 15599937
[TBL] [Abstract][Full Text] [Related]
19. FDG PET/CT manifestations of hematopoietic malignancies of the breast.
Ginat DT; Puri S
Acad Radiol; 2010 Aug; 17(8):1026-30. PubMed ID: 20547460
[TBL] [Abstract][Full Text] [Related]
20. JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-2. Related disorders of multiple myeloma.
Iida S; Shimazaki C; Abe M; Nakaseko C
Int J Hematol; 2019 Jun; 109(6):633-640. PubMed ID: 30963472
[No Abstract] [Full Text] [Related]
[Next] [New Search]
